--- title: "VitaDAO" url: "https://caper.network/wiki/desci/ecosystem/vitadao" updated: 2026-08-22 license: CC-BY-4.0 license_url: "https://creativecommons.org/licenses/by/4.0/" --- # VitaDAO | | | | --- | --- | | **Type** | DeSci DAO – longevity research | | **Founded** | June 2021 (first DeSci DAO) | | **Focus** | Funding early-stage longevity & aging science | | **Token** | VITA (governance-only, ERC-20) | | **Governance** | Snapshot (gasless, shielded); weight = VITA held. 129 proposals, 1,150,000 VITA quorum, 7-day voting period; most recent created 9 Sep 2025 | | **Governance forum** | [gov.vitadao.com](https://gov.vitadao.com/), a hosted Discourse instance. Unreachable when this page was written on 8 August 2026; resolving and serving the same threads again on 22 August 2026, most recent post 4 April 2026 | | **Legal steward** | Vitality Now, a Swiss association (Verein) – [VDP-160](https://gov.vitadao.com/t/vdp-160-vitality-now-association-setup-the-new-legal-steward-for-vitadao/1753), Dec 2024 | | **Ecosystem** | [Bio Protocol](/wiki/desci/ecosystem/bio-xyz) BioDAO | | **IP model** | [IP-NFTs](/wiki/desci/ip-nfts) ([Molecule](/wiki/desci/ecosystem/molecule) tooling); VITA-FAST / VITA-RNA IP tokens | | **Track record** | 31 projects funded, ~$4.7M deployed, 8 IP tokens generated, 3 companies spun out | | **Notable backers** | Pfizer Ventures, Shine Capital, Balaji Srinivasan | | **Chain** | Ethereum | | **Status** | 🟒 Active – [longevity newsletter published 14 August 2026](https://www.vitadao.com/blog); no binding Snapshot ballot since 9 September 2025 | | **Website** | [vitadao.com](https://www.vitadao.com) | ## Overview VitaDAO is [a community-owned collective that funds and advances early-stage longevity science](https://www.vitadao.com) – the first [decentralized science (DeSci)](/wiki/desci/what-is-desci) DAO, launched in June 2021 out of a [whitepaper by Tyler Golato and Paul Kohlhaas](https://www.vitadao.com/images/vita-labs/VitaDAO_Whitepaper.pdf) of [Molecule](/wiki/desci/ecosystem/molecule), and since grown into the largest organisation in the field. Its aim is to extend human healthspan by pooling community capital to de-risk translational aging research that traditional grant pipelines and venture funds routinely skip. VitaDAO operates as a BioDAO within the [Bio Protocol](/wiki/desci/ecosystem/bio-xyz) ecosystem (the network Molecule grew into) and holds a 21 million BIO allocation from Bio Protocol's bio/acc rewards programme in recognition of its founding role. [VDP-161](https://gov.vitadao.com/t/vdp-161-bio-token-airdrop-to-vitadao-community/1755) put 6.9 million of that allocation back out to the community as an airdrop – 80% (5.52M BIO) to VITA holders and 20% (1.38M BIO) to holders of its IP tokens, tiered by size of holding – and kept the remaining 14.1 million BIO in treasury to fund science. The stake gives VitaDAO a vote in governing new BioDAO launches and ecosystem incentives. The DAO reports [31 projects funded and roughly $4.7M deployed](https://www.vitadao.com), split across 3 target-discovery, 18 drug-discovery, 3 preclinical and 3 clinical drug-development projects, with 8 IP tokens generated and 3 companies founded. ## Governance and the VITA token $VITA is a [governance-only token](https://www.vitadao.com/blog/beginners-guide-to-vita-token): it confers no dividend and exists to steer the DAO. Voting happens on [Snapshot in a gasless, shielded format](https://gov.vitadao.com/t/how-to-vote-on-snapshot/490) – members must hold VITA in an Ethereum wallet, weight scales with the number of tokens held, and results stay hidden until the vote closes so early tallies don't sway later voters. This is textbook [token-weighted governance](/wiki/dao-governance/concepts/voting/voting-and-delegation), and it inherits token-weighted governance's core tension: influence tracks holdings, not contribution. Funding decisions escalate by size, and the ladder is written down rather than left to convention. Under the [VitaDAO constitution](https://gov.vitadao.com/t/vitadao-governance/787), a spend of $10,000 or less needs two working-group stewards to approve; above $10,000 and below $25,000, VitaCore approves by majority vote; from $25,000 to $50,000 the community decides by majority vote on the Discourse forum; and at $50,000 and above the decision goes to VITA holders on Snapshot. Any proposal from the Longevity Dealflow working group goes to Snapshot regardless of size. The constitution writes its top two tiers with a `≀` where the sense requires the opposite bound, so the numeric boundaries read as overlapping, but the escalation it describes is unambiguous: the larger the cheque, the wider the body that has to agree. Day-to-day work runs through specialist working groups (dealflow, tokenomics, awareness, legal and more) staffed by community stewards rather than a single executive team. Turnout at the binding stage is small in absolute terms and lopsided in outcome. [The vote.vitadao.eth Snapshot space](https://snapshot.box/#/s:vote.vitadao.eth) has carried 129 proposals against a 1,150,000 VITA quorum; the [VDP-163 FOXO3 oligos](https://gov.vitadao.com/t/vdp-163-funding-foxo3-oligos-revised/2033) funding vote closed on 16 September 2025 with 17 voters and 6,618,900 VITA cast entirely For, zero Against and zero Abstain, and the January 2025 BIO airdrop vote drew 37. Those are typical: proposals that reach Snapshot have usually been settled on the forum first, so the on-chain vote ratifies rather than decides – a pattern this wiki covers under [voter apathy](/wiki/dao-governance/concepts/analysis/voter-apathy). That space has recorded no new proposal since 9 September 2025. Who may _open_ a vote is a separate right from who may cast one, and this space grants them to different sets. [vote.vitadao.eth](https://snapshot.box/#/s:vote.vitadao.eth) restricts proposal creation to an author allowlist of thirteen addresses – five admins and eight members – which Snapshot documents as restricting proposals [β€œto authors only”](https://docs.snapshot.box/user-guides/spaces/settings) rather than validating a proposer's voting power against a threshold. Every VITA holder can vote; thirteen addresses decide what there is to vote on. That is an ordinary and defensible [proposal throttle](/wiki/dao-governance/concepts/voting/proposal-throttles-and-rate-limits), and it is also why the space's silence cannot be read as members declining to act: with the allowlist unchanged, a holder outside those thirteen addresses has no route by which to put VDP-164, or anything else, to a binding vote. The public-facing description has not followed the practice. VitaDAO's token page still presents VITA in the present tense as the instrument of governance – [β€œBy holding VITA, community members can vote on proposals to fund cutting-edge research, influence strategic decisions, and help steward the DAO's treasury”](https://www.vitadao.com/vita-token) – and the site's own β€œLaunch app” destination, `app.vitadao.com`, is a subscription longevity-AI product rather than a governance surface: its deployed JavaScript bundle, 391 KB read on 18 August 2026, contains no occurrence of `governance`, `proposal`, `vote`, or any Snapshot host. Governance did not move there, and it did not move up to [Bio Protocol](/wiki/desci/ecosystem/bio-xyz) either: the [documentation index](https://docs.bio.xyz/bio/llms.txt) for the platform that launched the BioDAO cohort lists no governance page at all, and its own vote-escrowed token is described as one that [β€œcan eventually confer voting rights in protocol governance (following veBIO gaining sufficient adoption in the system)”](https://docs.bio.xyz/bio/introduction/bio-protocol-v2/staking-and-vebio.md). The absence is checked against a sibling that shows presence: the same hub returns [CryoDAO](https://snapshot.box/#/s:vote.cryodao.eth)'s CRYO-26, closed 31 July 2026, so the reader is looking at one organization's silence rather than a dead venue. ## The Vitality Now Association In December 2024 VitaDAO's community approved [VDP-160, establishing Vitality Now](https://gov.vitadao.com/t/vdp-160-vitality-now-association-setup-the-new-legal-steward-for-vitadao/1753), a Swiss association (Verein), as the DAO's legal steward. The binding vote closed on 7 January 2025 with 862,378 VITA For, none Against and 334,534 Abstaining – 1,196,911 cast in total by 37 voters, roughly 4% clear of the space's 1,150,000 quorum, with more than a quarter of the weight cast declining to take a side. The proposal's framing is explicit about the division of labour: decision power stays with VitaDAO's governance mechanisms, and the association executes those decisions inside Swiss and international law. What the association actually holds is the part worth reading closely. Under VDP-160 it becomes the ultimate beneficial owner of all Pods – the semi-autonomous working units such as the Longevity Pod and the Web3 Pod – and it may own or control holding companies that manage projects and IP portfolios. It signs agreements with research institutions, core and strategic contributors, and service providers; it oversees IP acquisition, licensing and enforcement; and it manages contributors' multisignature wallets and payment streams alongside the Pods. Operational detail is delegated to VitaDAO's Guardians, the body responsible for strategic planning and the DAO's budgetary framework. This is the standard shape of a [DAO legal wrapper](/wiki/dao-governance/concepts/membership/dao-legal-structures): a recognised entity that can hold title, sign contracts, and answer to a regulator, sitting beneath a token vote that cannot do any of those things. The trade is equally standard. Everything the association controls – the IP portfolio, the holding companies, the multisigs, the contributor agreements – is governed on-chain only to the extent the association chooses to follow the vote, and members' recourse if it does not is Swiss association law rather than a smart contract. ## IP-NFTs and tokenized research The mechanism that distinguishes VitaDAO from an ordinary grants pool is how it holds what it funds. Rather than handing out cash and walking away, VitaDAO captures the intellectual property of funded projects as [IP-NFTs](/wiki/desci/ip-nfts) – on-chain assets, built with [Molecule](/wiki/desci/ecosystem/molecule)'s tooling, that the community can govern, license, and commercialise. This turns research IP into a treasury asset the DAO co-owns instead of an outcome it merely sponsors. VitaDAO went a step further with **VITA-FAST**, [the first IP-NFT to be fractionalised into an ERC-20 IP token](https://www.vitadao.com/blog/announcing-the-vita-fast-token-sale-for-viktor-korolchuk-lab). VITA-FAST represents shared ownership of the "Discovering Novel Autophagy Activators" IP-NFT from the Korolchuk Lab at Newcastle University, and its holders directly govern licensing decisions and experiment priorities for that specific research line. This is [tokenomics](/wiki/dao-governance/concepts/treasury/dao-tokenomics) in its most literal DeSci form: a tradeable claim minted directly against a real, governed research asset. The second IP token, **VITA-RNA**, shows what the pattern looks like once a programme is running for years. Its IP-NFT was tokenized in January 2024 and raised $300,000 for ARTAN Bio, whose lead candidate ARTAN-102 is an engineered suppressor tRNA delivered via AAV9 that reads through premature stop codons to restore full-length protein. The programme's milestones are reported through governance: two lead candidates validated in vitro from an initial screen of 15 oligos in October 2024, a first in vivo study in June 2025 reporting no adverse effects and broad biodistribution including the brain, and GMP process development at Lonza through September 2025. The reporting cadence is the point – an IP token gives holders a reason to be told, and a forum thread to be told in. ## Funding, Pfizer, and the token-versus-value question In January 2023 VitaDAO closed [a $4.1 million round](https://www.vitadao.com/blog/vitadao-closes-4-1m-fundraising-round-with-pfizer-and-shine-capital) whose backers included Pfizer Ventures, Shine Capital, L1 Digital, Beaker DAO, Spaceship DAO, and individuals such as Balaji Srinivasan and Joe Betts-LaCroix – following [Pfizer's initial $500k VITA purchase](https://longevity.technology/news/pfizer-invests-500k-in-vitadao-to-accelerate-longevity-rd/) in September 2022 that made it the first pharmaceutical company to hold a governance token and vote on a DAO proposal. That commercialisation raised a familiar structural problem. In April 2023 VitaDAO members [voted to create a for-profit company](https://www.coindesk.com/business/2023/04/05/pfizer-backed-vitadao-votes-on-creating-for-profit-company-to-fund-longevity-research) to carry assets through the capital-intensive stages a community treasury can't underwrite – the same token-versus-equity split [AthenaDAO](/wiki/desci/ecosystem/athenadao) later reached for with AthenaBIO. A freely-traded governance token's price drifts away from the value of the underlying science, so the DAO governs and sources while separate legal vehicles hold and commercialise the work. The Vitality Now structure above is where that split ended up: an association at the top, Pods beneath it, and holding companies beneath those. ## The senior review, and a proposal that never reached a vote Token voting decides whether a grant is popular. It does not decide whether the science is any good, and VitaDAO layers a scored expert gate in front of the vote to close that gap. The clearest published example is [VDP-164](https://gov.vitadao.com/t/vdp-164-vitadao-funding-proposal-500k-loan-to-advance-vitarna-through-non-glp-toxicology-toward-2026-ind-submission/2052), proposed on 16 September 2025: a $500,000 loan to [VITARNA](/wiki/desci/ecosystem/vitarna)/ArtanBIO, recoverable in a later fundraise, to fund GMP manufacturing and non-GLP toxicology in non-human primates ahead of a targeted 2026 IND submission. After the forum poll, four reviewers – two biotech entrepreneurs, one biotech VC and one pharma VC, two of them former scientists – scored the proposal out of 5 across seven categories. The published averages were Team Expertise 3.0, Feasibility & Data 2.5, Commercial Potential & Impact 2.0, Novelty & Market Advantage 3.0, IP Defensibility 3.5, Relevance to Longevity 2.5 and Deal Terms 2.5, for an **overall conviction score of 2.3 against an average of 3.7 for past funded projects**. Asked whether they would endorse it, one reviewer said only after more robust delivery, efficacy and IP data; one said conditionally, contingent on a rigorous preclinical package and a narrowed initial indication; and one said no, on the grounds that the mechanism had not been shown to address a meaningful driver of aging. Publishing the digest then produced a second argument, about the review rather than the science. On 26 February 2026 a member [objected in the thread](https://gov.vitadao.com/t/vdp-164-vitadao-funding-proposal-500k-loan-to-advance-vitarna-through-non-glp-toxicology-toward-2026-ind-submission/2052) that only a qualitative summary had been posted, and asked for the reviewer document and the team's written response to be published in full; ARTAN Bio's own chief executive agreed, writing that the community should be able to read the reviews rather than rely on anonymous reviewers whose credentials no one could check. VitaDAO replied on 3 March 2026 that the format matched previous proposals and that it was open to sharing more detail. Nobody posted again. The governance outcome is the part that generalises. VDP-164 has never appeared on [VitaDAO's Snapshot space](https://snapshot.box/#/s:vote.vitadao.eth), whose most recent proposal was created on 9 September 2025 – a week before VDP-164 was posted. The constitution's escalation ladder says a request this size needs the community's approval _and_ a Snapshot vote, and a Longevity Dealflow proposal needs the Snapshot vote whatever its size; in practice the proposal has spent its entire life at the forum-and-review stage, and the binding vote it would have to clear has not been called. A scored expert gate is a real answer to token voting's competence problem, and this is its characteristic failure mode: a low score does not reject a proposal, it strands one, and the record of what happened next lives in a forum thread rather than in a vote anyone can point to. The same tension runs through [scoring and review gates](/wiki/dao-governance/concepts/analysis/scoring-and-review-gates) and [DAO procurement and RFPs](/wiki/dao-governance/concepts/analysis/dao-procurement-and-rfps), where a scoring panel decides who is even eligible to be voted on, and through [DeSci funding](/wiki/desci/desci-funding) more broadly. ## The forum went offline, and came back Every VitaDAO source cited above points at `gov.vitadao.com`, the DAO's hosted Discourse forum. On 8 August 2026 that hostname did not resolve. It is a CNAME to `vitadao.hosted-by-discourse.com`, and the target carried no address record at either Cloudflare's or Google's public resolver, so a request failed before it reached a server. This page was rewritten around that failure, and every forum citation on it was repointed at the Internet Archive. The outage ended. Re-probed on 22 August 2026, the CNAME target answers `184.104.178.43` at both public resolvers and [gov.vitadao.com](https://gov.vitadao.com/) serves its topic list again. It is the same instance rather than a fresh one: the [VDP-164 thread](https://gov.vitadao.com/t/vdp-164-vitadao-funding-proposal-500k-loan-to-advance-vitarna-through-non-glp-toxicology-toward-2026-ind-submission/2052) still ends on the 3 March 2026 reply described above, and the forum's most recent activity anywhere is an introduction posted on 4 April 2026. Every citation on this page has been repointed back at the live thread. The episode stays on the page because what it exposes is a hole in the checking rather than a fault of VitaDAO's. Swapping an archived copy in for a dead URL is the standard repair, and it quietly converts a checkable claim into an unfalsifiable one: a link checker asks whether a URL resolves, `web.archive.org` always resolves, and nothing ever re-asks whether the original came back. An outage is a state, not an event. This page went on asserting a fortnight-old DNS failure as a settled fact while every automated check it is subject to passed. The durability argument the outage prompted survives the recovery, because what came back came back at somebody else's discretion. The [vote.vitadao.eth Snapshot space](https://snapshot.box/#/s:vote.vitadao.eth) returned all 129 proposals, their choices, their per-option scores and their voter counts to any keyless query throughout, because a Snapshot vote is a signed message on shared infrastructure rather than a page on a rented one. The forum did not, for at least a fortnight. A DAO that keeps its binding votes on-chain and its reasoning on a hosted forum has split its record across two very different durability guarantees, and under VitaDAO's own ladder the hosted half carries the most decisions: everything below $50,000 is settled by stewards, by VitaCore, or by a forum poll, and none of those leaves an on-chain trace. Neither does a proposal that is scored, argued over, and then never put to a vote. ## How Caper approaches this The token-versus-value gap VitaDAO patches with a legal wrapper and a separate commercial vehicle is the seam a [caper](/wiki/foundations/what-is-a-caper) is built to close. On Caper, contributed capital flows into the caper's own [bonding-curve](/wiki/markets/bonding-curve) treasury rather than into a free-floating governance token whose price detaches from the work – value accrues to the treasury itself, and members hold a [participation-weighted claim](/wiki/dao-governance/concepts/membership/rage-quit-and-exit-rights) on it. Research spending is authorised the way any spend is: a [PAYOUT proposal](/wiki/governance/proposals) that moves a chosen currency and amount from the [treasury](/wiki/dao-governance/concepts/treasury/dao-treasury-management) to a lab once members [vote it through](/wiki/governance/voting). Voting weight is stake weighted by participation rather than raw token balance, so the people funding the science keep governance coupled to their exposure – and there is no separate equity vehicle to stand up to keep the token's price from wandering off from the value being built. Caper has no view on which science is worth funding, and nothing in the protocol substitutes for the expert judgement a senior review supplies. What it does change is where a proposal can stall: every proposal a caper's members raise runs to a decision on-ledger, so a funding request either passes or fails on the record rather than lapsing between a review and a vote that is never called. There is also no size threshold below which a spend skips the record: a caper's treasury pays out on an executed proposal, and the proposal, each ranked ballot cast against it, and its execution are all state and events on the caper's own component. The one other way value leaves a caper's treasury is a member taking their exit, and that too is a ledger event rather than a decision recorded somewhere else. It is a narrower record than a forum thread, and the trade is honest: less discussion preserved, none of what is preserved revocable by a lapsed hosting bill. ## External links - [VitaDAO – official website](https://www.vitadao.com) - [VitaDAO on Snapshot (vote.vitadao.eth)](https://snapshot.box/#/s:vote.vitadao.eth) – the live vote record, 129 proposals - [VitaDAO whitepaper (PDF)](https://www.vitadao.com/images/vita-labs/VitaDAO_Whitepaper.pdf) - [VitaDAO governance forum](https://gov.vitadao.com/) – live again on 22 August 2026 after the outage this page recorded on 8 August ([category index](https://gov.vitadao.com/categories)) - [VitaDAO Governance constitution](https://gov.vitadao.com/t/vitadao-governance/787) – the escalation ladder and proposal types - [VDP-160 – Vitality Now Association setup](https://gov.vitadao.com/t/vdp-160-vitality-now-association-setup-the-new-legal-steward-for-vitadao/1753) - [VDP-161 – BIO token airdrop to the VitaDAO community](https://gov.vitadao.com/t/vdp-161-bio-token-airdrop-to-vitadao-community/1755) - [VDP-164 – $500K VITARNA loan, with the senior-review digest](https://gov.vitadao.com/t/vdp-164-vitadao-funding-proposal-500k-loan-to-advance-vitarna-through-non-glp-toxicology-toward-2026-ind-submission/2052) - [VitaDAO on X](https://x.com/vitadao)